SCHEMBL11300

SCHEMBL11300

OCCN1CCOCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4820784 1.00
SCHEMBL13758294 1.00 KDM4E (0.90)
SCHEMBL25262333 1.00 KDM4E (0.90)
SCHEMBL16604261 0.97 KDM4E (0.95)
Iodide SCHEMBL14778132 0.97 KDM4E (0.86)
SCHEMBL12958952 0.97 KDM4E (0.95)
Bromide SCHEMBL11805132 0.97 KDM4E (0.86)
SCHEMBL11200585 0.97 KDM4E (0.95)
SCHEMBL5662669 0.97 KDM4E (0.95)
SCHEMBL10955826 0.97 KDM4E (0.95)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 25424 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204609-B1 COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER MACDERMID ENTHONE INC (US) 2026-05-27 EP claimed
WO-2026107083-A2 SHELF-STABLE LOXSH CATALYST SOLUTION COMPOSITIONS COMPRISING SOLUBLE HIGH HYDRIDE CONCENTRATIONS AND THE PROCESSES FOR PREPARING THEM ALBEMARLE CORPORATION (US) 2026-05-21 WO claimed
CN-122037116-A Combined polyether, polyurethane composition, polyurethane foam, preparation method of polyurethane foam and refrigeration equipment TCL家用电器(合肥)有限公司 2026-05-15 CN claimed
US-12616699-B2 Ophthalmic formulations of methotrexate ALDEYRA THERAPEUTICS, INC. (US) 2026-05-05 US claimed
EP-3938414-B1 A TWO-COMPONENT POLYURETHANE OR POLYISOCYANURATE SPRAY FOAM COMPOSITION CONTAINING A HYDROHALOOLEFIN BLOWING AGENT DDP SPECIALTY ELECTRONIC MATERIALS US LLC (US) 2026-04-01 EP claimed
US-20260068874-A1 AGROCHEMICAL FORMULATION SOLVENTS ROSENS INC (US) 2026-03-12 US claimed
WO-2026044024-A1 COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF I2O THERAPEUTICS, INC. (US) 2026-02-26 WO claimed
US-12559704-B2 Microelectronic device cleaning composition ENTEGRIS, INC. (US) 2026-02-24 US claimed
US-20260021118-A1 LOW-SORBING GLYBURIDE FORMULATION AND METHODS REMEDY PHARMACEUTICALS, INC. (US) 2026-01-22 US claimed
EP-4124640-B1 NOVEL USE FOR COOLANTS WITH LOW ELECTRICAL CONDUCTIVITY BASF SE (DE) 2026-01-21 EP claimed
EP-0002895-A1 Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof, and process for their manufacture IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1979-07-11 EP claimed
US-4130510-A Curing of epoxy resin systems using halfester compounds containing aliphatic tertiary amino groups HITACHI CHEMICAL CO., LTD. (JP) 1978-12-19 US claimed
US-4103087-A REACTING TERTIARY AMINOALKANOL WITH A SECONDARY AMINE IN PRESENCE OF AN ALUMINUM PHOSPHATE CATALYST TEXACO DEVELOPMENT CORPORATION (US) 1978-07-25 US claimed
US-4095022-A PHOSPHORUS COMPOUNDS, SILICA-ALUMINA CATALYST TEXACO DEVELOPMENT CORPORATION (US) 1978-06-13 US claimed
US-4087245-A Process for the preparation of concentrated solutions of anionic dyestuffs BAYER AKTIENGESELLSCHAFT (DT) 1978-05-02 US claimed
US-4067916-A TELOMERIZATION WITH A PERFLUOROETHYLENE OR PERFLUOROPROPYLENE CIBA-GEIGY AG (CH) 1978-01-10 US claimed
US-4052331-A SURFACE ACTIVE COMPOSITION RHONE-POULENC S.A. (FR) 1977-10-04 US claimed
US-4026935-A FROM N-(HYDROXYALKYL)-MORPHOLINE COMPOUND, SILICA-ALUMINA CATALYST TEXACO DEVELOPMENT CORPORATION (US) 1977-05-31 US claimed
US-3975294-A POLYETHYLENE GLYCOL, MONOETHER; SODIUM DIALKYLSULFOSUCCINATE; OLEIC, LINOLEIC, LINOLENIC OR RICINOLEIC ACID; TRIETHANOLAMINE OR N-HYDROXYETHYLMORPHOLINE RHONE-POULENC S.A. (FR) 1976-08-17 US claimed
US-3974275-A 1,4-Dihydropyridine carboxylic acid esters useful as coronary vessel dilators and anti-hypertensives BAYER AKTIENGESELLSCHAFT (DT) 1976-08-10 US claimed